← 返回列表 › SCI 期刊 › 医学 › SEMIN THROMB HEMOST

Seminars in Thrombosis and Hemostasis

SEMIN THROMB HEMOST

Print ISSN 0094-6176 Online ISSN 1098-9064
SCIE Q1 新锐3区 综述期刊 医学
影响因子 2026
4.2
↑ 0.1
5年均分
3.8
5-Year IF
H 指数
92
H-Index
年发文量
97
Articles / Year
出刊频率
Bimonthly
Pub. Frequency
创刊年份
1974
Founded Year
出版商
Thieme Medical Publ Inc
Publisher
出版国家
USA
Country
投稿参考 & 用户评分
🏆 期刊声誉
★★★★★
暂无
综合口碑评分,点击星星参与
⚡ 审稿速度
★★★★★
系统
暂无
约 2.8 个月
💰 版面费用
★★★★★
暂无
暂无APC数据,欢迎分享经验
中科院分区
2026新锐分区 新体系
大类3区
医学Medicine
小类2区
血液学Hematology
中科院2025年分区 传统体系
大类3区
医学Medicine
小类3区
血液学Hematology
WoS 期刊 JCR 分区 (2026 · JIF) 综合 SCIE Q1
学科 收录集 JIF 分区 JIF 排名 JIF 百分位
周围血管疾病 Peripheral Vascular Disease SCIE Q1 23/100
77.0%
血液学 Hematology SCIE Q1 24/103
76.7%
按 JCI 指标学科分区
学科 收录集 JCI 分区 JCI 排名 JCI 百分位
周围血管疾病 Peripheral Vascular Disease SCIE Q1 23/92 JCI 0.84
76.1%
血液学 Hematology SCIE Q2 25/87 JCI 0.84
72.4%
Scopus 指标
CiteScore
8.8
综合引用得分
SJR
1.095 Q1
SCImago Journal Rank
SNIP
1.180
Source Normalized Impact
JCI
0.84
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

Seminars in Thrombosis and Hemostasis (SEMIN THROMB HEMOST) is a peer-reviewed medical journal dedicated to advancing the understanding and clinical management of thrombotic and bleeding disorders. Published by Thieme Medical Publishers, the journal provides in-depth, focused coverage of hemostasis, coagulation, fibrinolysis, platelet function, and vascular biology. Its scope encompasses both fundamental research and practical clinical applications, with particular emphasis on thrombosis, anticoagulant therapy, hemorrhagic diseases, and laboratory diagnostics. The journal primarily publishes invited review articles and state-of-the-art thematic issues, each curated by expert guest editors, though original research and case reports are also considered. Each issue typically centers on a specific topic, offering a comprehensive synthesis of current knowledge, emerging therapies, and diagnostic challenges. The target audience includes hematologists, vascular medicine specialists, pathologists, clinical laboratory scientists, and researchers in coagulation and thrombosis. Notably, the journal operates under a traditional subscription model with select open access options available through author choice. With a 2026 Impact Factor of 4.200 and a JCR Quartile ranking of Q1 in its category, Seminars in Thrombosis and Hemostasis is recognized as a leading authoritative resource in the field. Its consistently high impact factor and top-tier quartile placement underscore its significant influence on both clinical practice and translational research, making it an essential reference for professionals seeking rigorous, expert-driven syntheses of complex hemostatic and thrombotic topics.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.